Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses, and Lymphoma Diagnosis and Treatment.
Expression and prognostic significance of CD93 in blood vessels in colorectal cancer: an immunohistochemical analysis of 134 cases
<scp>CNDP1</scp> Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal Melanoma
The physiological characteristics of inward rectifying potassium channel Kir4.2 and its research progress in human diseases
Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma
The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11
Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study
Effective Combination of Targeted Therapies with Sonodynamic Treatment for Use in Exploring Differences in Therapeutic Efficacy across Organelle Targets
Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancer
<scp>CXCL8</scp> induces <scp>M2</scp> macrophage polarization and inhibits <scp>CD8</scp> <sup>+</sup> T cell infiltration to generate an immunosuppressive microenvironment in colorectal cancer
TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment
Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer
Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry
siRNA-Based Approaches for Castration-Resistant Prostate Cancer Therapy Targeting the Androgen Receptor Signaling Pathway
Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening
Photothermal effects of supra-CNDs@GelMA composite hydrogels under near-infrared stimulation
Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma
Lycium Barbarum polysaccharides ameliorates hyperglycemia-exacerbated cerebral ischemia/reperfusion injury via protecting blood-brain barrier
JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK− Anaplastic Large Cell Lymphomas
Subclassifying triple-negative breast cancers and its potential clinical utility
Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Polymorphisms of adiponectin gene and gene–lipid interaction with hypertension risk in Chinese coal miners: A matched case-control study
The Role of <i>DBR1</i> as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma
miR‐148a‐3p silences the CANX/MHC‐I pathway and impairs CD8 <sup>+</sup> T cell‐mediated immune attack in colorectal cancer
Radiomics Features at Multiparametric MRI Predict Disease-Free Survival in Patients With Locally Advanced Rectal Cancer
The Clinicopathological Characteristics and Prognoses of dMMR Gastric Adenocarcinoma Patients
PD-L1 Protein Expression and Gene Amplification Correlate with the Clinicopathological Characteristics and Prognosis of Lung Squamous Cell Carcinoma
Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma
Aberrant expression and genetic alteration of c-MYC in anaplastic large cell lymphoma
Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma